Skip to Content
🌐Ship toSelect country

Neauvia Hydro Deluxe - 2 x 2,5ml

Neauvia Hydro Deluxe is a non-cross-linked (linear) hyaluronic acid hydrogel from Matex Lab's Neauvia PEG-HA range, containing 18mg/ml HA plus 0.01% calcium hydroxyapatite (CaHA). Injected into the dermis and epidermis, it is designed for skin regeneration, superficial wrinkle correction and rejuvenation of thin-skinned areas such as the hands, functioning as a biorevitalising skinbooster rather than a volumising filler. CE Class III medical device, manufactured by Matex Lab SpA (Italy). For use by licensed, trained medical professionals only.

59.00 € 59.00 €
  • Brand
Terms and Conditions

Shipping: 
DHL EXPRESS SHIPPING (EU) — approx. 2-3 working days
STANDARD SHIPPING (EU) — approx. 7-10 working days
Select your delivery country in the header to check availability for your destination.
Category Mesotherapy Brand Neauvia
SKU A3001 Share
Treatment Areas Face
Tags Hyaluronic AcidHydrationStretch mark reduction

Neauvia Hydro Deluxe is a hybrid hyaluronic-acid and calcium-hydroxyapatite skin booster from Matex Lab's Neauvia range, combining 18mg/ml HA with 0.01% CaHA microparticles. This hybrid formulation is designed to deliver deep hydration alongside a mild biostimulatory effect, improving skin quality without adding volume.

CONCENTRATION

  • Hyaluronic acid 18mg/ml + calcium hydroxyapatite (CaHA) 0.01%

THE PACK INCLUDES

  • 2 x 2.5ml Syringes

STORAGE CONDITIONS

  • Store between 2°C and 25°C
  • Do not freeze

RESULTS & DURATION

Results typically last 6-9 months, with a course of sessions recommended for best effect.

INDICATIONS

  • Skin dehydration and dullness
  • Loss of skin elasticity
  • Early signs of ageing

TREATMENT AREAS

  • Face
  • Neck
  • Décolleté
  • Hands

Neauvia Hydro Deluxe is administered via intradermal microinjections using mesotherapy technique.

A course of 2-3 sessions at 3-4 week intervals is typically recommended, with maintenance sessions thereafter.

  • Pregnancy or breastfeeding
  • People under the age of 18
  • Active infection or inflammation at the treatment site
  • Known hypersensitivity to hyaluronic acid
  • Patients prone to hypertrophic scarring
  • Autoimmune diseases affecting the skin